Skip to main content

Research Repository

Advanced Search

Recommended and observed statin use among US adults with and without cancer.

Kobo, Ofer; Michos, Erin D; Roguin, Ariel; Bagur, Rodrigo; Gulati, Martha; Mamas, Mamas A

Authors

Ofer Kobo

Erin D Michos

Ariel Roguin

Rodrigo Bagur

Martha Gulati



Abstract

Patients with cancer are at increased cardiovascular risk. We aimed to compare the recommended and observed statin use among individuals with and without cancer. Using three 2-year cycles from the National Health and Nutrition Examination Survey [NHANES] (2013-2018), we analyzed data from 17,050 USA adults. We compared the prevalence of class 1 statin recommendations and use between individuals with and without cancer, overall and among different demographic groups. Individuals with a history of cancer were older and had a higher burden of co-morbidities. Stratified by age groups, they were more likely to have a secondary prevention indication compared to individuals without cancer, but not a primary prevention indication for statin. Among individuals with an indication for statin therapy, the prevalence of statin use was higher in the cancer group compared to those without cancer (60.8% vs 47.8%, p < 0.001), regardless of sex, type of indication (primary vs secondary prevention), and education level. However, the higher prevalence of statin use in the cancer group was noted among younger individuals, ethnic minorities, and those with lower family income. Our finding highlights the importance of optimization of cardiovascular health in patients with cancer, as Individuals with cancer were more likely to have a class 1 indication for statin treatment when compared to individuals without cancer. Important differences in statin use among cohorts based on sex, age, ethnicity, and SES were identified, which may provide a framework through which cardiovascular risk factor control can be targeted in this population. [Abstract copyright: © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.]

Citation

Kobo, O., Michos, E. D., Roguin, A., Bagur, R., Gulati, M., & Mamas, M. A. (in press). Recommended and observed statin use among US adults with and without cancer. European Journal of Preventive Cardiology, Article zwae057. https://doi.org/10.1093/eurjpc/zwae057

Journal Article Type Article
Acceptance Date Feb 5, 2024
Online Publication Date Feb 9, 2024
Deposit Date Feb 26, 2024
Journal European journal of preventive cardiology
Print ISSN 2047-4873
Electronic ISSN 2047-4881
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
Article Number zwae057
DOI https://doi.org/10.1093/eurjpc/zwae057
Keywords Statin; Cardio-oncology; Prevention
Publisher URL https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwae057/7604140